**Introduction:** Patterns of atrophy can distinguish normal cognition from Alzheimer's disease (AD), but neuropathological drivers of this pattern are unknown. This study examined associations between cerebrospinal fluid biomarkers of AD pathology, …
**Background:** Subclinical reductions in cardiac output correspond to lower cerebral blood flow (CBF), placing the brain at risk for functional changes.
**Objectives:** This study aims to establish the consequences of reduced cardiac output on …
**Introduction:** Neuroaxonal damage may contribute to cognitive changes preceding clinical dementia. Accessible biomarkers are critical for detecting such damage. **Methods:** Plasma and cerebrospinal fluid (CSF) neurofilament light (NFL) were …
**Background:** Blood pressure visit-to-visit variability is a novel risk factor for deleterious long-term cardiac and renal outcomes in the general population. We hypothesized that patients with systemic lupus erythematosus (SLE) have greater blood …
**Objective:** To compare the risk of resistant hypertension (RHTN) in patients with systemic lupus erythematosus (SLE) and in controls without SLE, and to define factors associated with RHTN in patients with SLE. **Methods:** We studied 1,044 …
**Background:** Global longitudinal strain (GLS), reflecting total shortening of the myocardium during the cardiac cycle, has emerged as a more precise myocardial function measure than left ventricular ejection fraction (LVEF). Longitudinal strain …
A series of 2‐alkyl/aryl‐4H‐benzo[1,4]thiazine‐3‐ones have been synthesized by microwave irradiation of ethyl‐2‐bromo‐2‐alkyl/aryl acetate and 2‐amino thiophenol in the presence of 1,8‐diazabicyclo‐[5.4.0] undec‐7‐ene and N‐methylpiperidine. All …
4,4‐Dialkyl and 4,4‐diaryl‐4H‐benzo[d][1,3]oxathiin‐2‐ones were synthesized by the reaction of 2‐(mercapto‐phenyl)‐dialkyl‐ (or diaryl)‐methanol with CDI in excellent yield. The 2‐(mercaptophenyl)‐dialkyl‐ (or diaryl)‐methanols were prepared by the …